Asterand Wins 5-Year, $24.3 Million Contract From National Cancer Institute
DETROIT - Asterand plc, a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, has been awarded a five-year, $24.3 million contract with the National Cancer Institute to supply clinically annotated human biospecimens for The Cancer Genome Atlas project, which attempts to understand the molecular